Although clozapine (CZP), which is used for schizophrenia treatment, causes weight gain, the mechanism remains unclear. We recently reported that the naturally occurring compound curcumin (CUR) suppresses adipogenesis in 3T3-L1 cells. The aims of the present study were to determine the mechanism by which CZP induces adipocyte differentiation of 3T3-L1 cells, and whether CUR reduces CZP-induced adipogenesis. We found that cells grown in the presence of CZP had significantly higher triacylglycerol levels, numbers of lipid-filled adipocytes, and mRNA expression levels of CCAAT-enhancer binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ) than those grown without CZP. Treatment with CZP plus CUR resulted in major reductions in these four parameters. These results suggest that CZP enhances adipogenesis in 3T3-L1 cells via the C/EBPα-PPARγ pathway and that by interrupting CZP's effects, CUR might be a potent agent for preventing CZP-induced weight gain.
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(5HT 2C ), dopamine D2 (D 2 ), and histamine 1 (H 1 ) in the central nervous system [2] . In the last decade, it has been suggested that second-generation atypical antipsychotic drugs cause body weight gain not only by affecting the receptors of the central nervous system but also by directly affecting peripheral adipogenesis [3] - [8] . However, the mechanism by which second-generation atypical antipsychotic drugs directly induce adipocyte differentiation remains unclear.
Over the years, many phytochemical compounds have been found to have a high capacity to act against various disorders, including metabolic syndrome.
One of these substances, curcumin (CUR), a nutraceutical and pharmaceutical, is the active ingredient in turmeric, a well-known Indian spice derived from the dried roots of the Curcuma longa plant. The effects of CUR in metabolic syndrome have been studied in several clinical trials. In these trials, CUR improved the lipid profiles and modified the cholesterol-related parameters of the subjects [9] [10] . Furthermore, CUR can improve anthropometric measurements and body composition when taken as part of the diet together with the implementation of appropriate lifestyle interventions [11] .
3T3-L1 preadipocytes are extensively used as an in vitro model for studying adipogenesis. Our laboratory [12] and other groups [13] [14] [15] have reported that CUR suppresses the adipogenic differentiation of 3T3-L1 preadipocytes by downregulating the CCAAT-enhancer binding protein α (C/EBPα)-peroxisome proliferator-activated receptor γ (PPARγ) pathway, which is a major adipogenesis pathway [16] [17] . Thus, the present study was designed to determine whether CZP induces adipocyte differentiation of 3T3-L1 cells via the C/EBPα-PPARγ pathway. Furthermore, to our knowledge, this is the first study to evaluate whether CUR could interrupt CZP-induced adipogenesis.
Materials and Methods

Materials
Mouse 3T3-L1 preadipocytes were obtained from the European Collection of 
Treatments with CZP and CUR
CZP and CUR were prepared in dimethyl sulfoxide (Me 2 SO) and added to the growth, initiation, and maturation media from day 3 (time of addition of dexamethasone, IBMX, and insulin) to day 9 (the end of the experiment). The 
Oil Red O Staining
The cells were fixed in 4% formaldehyde-phosphate buffer (pH 7.4) for 1 h, rinsed with water, and stained with 0.3% Oil Red O dye for 1 h. After washing again with water, the cells were monitored using a microscope (10 × 20 magnification).
Quantification of Mature Adipocytes
Mature adipocytes in the culture were quantified using Lipid Droplets Fluores- 
Determination of TG Levels
The cells were harvested by scraping them from the culture dishes into lysis buffer (1% Triton-100, 150 mM NaCl, 4 mM ethylenediaminetetraacetic acid, and 20 mM Tris-HCl [pH 7.4] containing a protease inhibitor cocktail) and lysed completely using a horn-type sonicator. The TG level, which is an index of lipid accumulation, was determined using Triglyceride E-test Wako kit following normalization of the protein amounts and expressed as TG content (µg/mg protein). 
Determination of the mRNA Expression
Statistical Analysis
The results are expressed as the mean ± standard error of the mean values. Significant differences in data between two groups were assessed using Student's t-test. Differences were considered statistically significant at P < 0.05. 
Results
CZP Promotes the Differentiation of 3T3-L1 Cells
CUR Interferes with CZP-Induced Adipogenesis in 3T3-L1 Cells
To study the potential inhibitory effects of CUR on CZP-induced adipogenesis, 20 µM CUR was added to the culture medium together with CZP (20 µM) during the differentiation of the 3T3-L1 cells. Changes in differentiation were monitored by determining the TG levels ( Figure 1 Compared to exposure to DM alone, exposure to both 20 µM CZP and DM resulted in a significant increase in TG levels (1.3 fold in Figure 1(b) ), Oil Red O-stained cells (Figure 2(a) ), and percentage of lipid-filled adipocytes as shown by Nile Red and flow cytometry (2.4 fold in Figure 2(c) ). However, the administration of 20 µM CUR with CZP almost nullified the effects of CZP; the TG levels (Figure 1(b) ), number of Oil Red O-stained cells (Figure 2(a) ), and percentage of lipid-rich adipocytes (Figure 2(c) ) were similar to the respective levels in the presence of DM or CUR alone. The results shown in Figure 1(b) and Figure 2 demonstrate that CUR interferes with the CZP-induced adipogenesis in 3T3-L1 cells.
CUR Disrupts the Effect of CZP at the Site of the C/EBPα-PPARγ Pathway
As shown in Figure 3 
Discussion
Generally, patients responding to CZP should continue maintenance treatment on their effective dose beyond the acute episode. Several studies have assessed the relationship between plasma CZP levels and clinical responses [21] . Most studies have found that a threshold plasma level of 1.1 -2.6 µM CZP is associated with an increased probability of a good clinical response to the drug. Together with C/EBPα, PPARγ promotes terminal differentiation by activating the expression of downstream adipocyte-specific genes.
In the present results, we showed that CZP at 5 µM or less concentration potentiated TG accumulation in 3T3-L1 cells (Figure 1(a) ). Additionally, compared to exposure to DM alone, 20 µM CZP exposure significantly increased the mRNA expression levels of PPARγ and C/EBPα ( Figure 3) . Thus, the present study confirms that CZP at clinical levels causes body weight gain partially by directly affecting peripheral adipogenesis. It might be also possible that the CZP-induced adipogenesis is partially ascribed to enhancement of the C/EBPα-PPARγ pathway.
Humans can consume up to 8 grams of CUR per day without experiencing toxic effects [24] ; this makes CUR a very interesting potential preventive agent against various diseases. CUR has been reported to inhibit adipogenesis in both cellular and animal models of obesity by several research groups, including ours [9] - [15] . In addition, recent clinical trials have demonstrated that CUR can reduce blood TG levels in patients with type II diabetes [25] [26] .
In the present study, the level of adipogenesis in cells treated with 20 µM CZP plus 20 µM CUR was almost identical to that in the cells that were not treated with CZP (Figure 1(b) and Figure 2 ). Furthermore, the results shown in Figure 3 demonstrate that CUR reversed the CZP-induced increments in the mRNA expression of PPARγ, and C/EBPα. These results suggest that because of its ability to inhibit the effects of CZP, CUR might be a potent naturally occurring compound that prevents CZP-induced weight gain, thus preventing obesity and worsening of obesity-related complications.
Conclusion
In conclusion, to our knowledge, this is the first study to show that CUR could inhibit CZP-induced weight gain and its complications via inhibition of adipocyte differentiation. Our results suggest that CUR has the potential to prevent the side effects of atypical antipsychotic drugs.
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